SEC Form 4 · accession 0001209191-15-036806
Anacor Pharmaceuticals, Inc. · ANAC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul L Berns
Officer — President and CEO · Director
Period of report
Apr 24, 2015
Accepted (ET)
Apr 28, 2015 · 8:37 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001411158
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 20, 2015 | G | 5,000 | $0.00 | D | 303,760 | D | |
| Common StockF3,F4 | Apr 24, 2015 | S | 7,833 | $64.6874 | D | 295,927 | D | |
| Common StockF3,F5 | Apr 24, 2015 | S | 16,267 | $65.5067 | D | 279,660 | D | |
| Common StockF3,F6 | Apr 24, 2015 | S | 900 | $66.3144 | D | 278,760 | D | |
| Common StockF3,F7 | Apr 27, 2015 | S | 7,624 | $59.7895 | D | 271,136 | D | |
| Common StockF3,F8 | Apr 27, 2015 | S | 2,078 | $60.458 | D | 269,058 | D | |
| Common StockF3,F9 | Apr 27, 2015 | S | 2,100 | $61.7417 | D | 266,958 | D | |
| Common StockF3,F10 | Apr 27, 2015 | S | 3,448 | $62.6847 | D | 263,510 | D | |
| Common StockF3,F11 | Apr 27, 2015 | S | 9,750 | $63.8546 | D | 253,760 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Reflects a bona fide charitable gift of shares donated by the reporting person.
- F10These shares were sold in multiple transactions at prices ranging from $62.38 to $63.30, inclusive.
- F11These shares were sold in multiple transactions at prices ranging from $63.50 to $64.41, inclusive.
- F2This sale was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person for tax and estate planning purposes.
- F3The price reported in Column 4 is a weighted average price.
- F4These shares were sold in multiple transactions at prices ranging from $64.00 to $64.94, inclusive.
- F5These shares were sold in multiple transactions at prices ranging from $65.04 to $65.99, inclusive.
- F6These shares were sold in multiple transactions at prices ranging from $66.11 to $66.47, inclusive.
- F7These shares were sold in multiple transactions at prices ranging from $59.16 to $60.10, inclusive.
- F8These shares were sold in multiple transactions at prices ranging from $60.16 to $61.06, inclusive.
- F9These shares were sold in multiple transactions at prices ranging from $61.20 to $62.10, inclusive.